analyst
ER
NASDAQ · ERAS
Erasca, Inc.
Healthcare · Biotechnology
$14.30
Down-$0.42 (-2.85%)
Updated Oct 7, 2026, 3:16 AM
SID Score
5.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 958.95M
- P/E ratio
- -7.47
- Dividend yield
- 0.00%
- 52-week range
- $2.11 – $24.28
- Volume
- 8.04M
- Avg. volume
- 1.84M
Price performance · ERAS
ERAS price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 6, 2026
ERAS closed at $14.30 after 21 trading sessions, down 12.16% for the selected period.
- Last close
- $14.30
- Period change
- -12.16%
- Period low
- $13.95
- Period high
- $16.28
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 6, 2026 | $14.74 | $14.93 | $14.02 | $14.30 | 8.04M |
| Oct 5, 2026 | $14.74 | $15.03 | $13.8034 | $14.72 | 5.49M |
| Oct 2, 2026 | $14.81 | $15.265 | $14.57 | $14.74 | 3.84M |
| Oct 1, 2026 | $14.66 | $15.01 | $14.33 | $14.58 | 3.69M |
| Sep 30, 2026 | $14.37 | $15.12 | $14.1101 | $14.66 | 5.29M |
| Sep 29, 2026 | $14.10 | $14.43 | $13.82 | $14.21 | 3.2M |
| Sep 28, 2026 | $14.525 | $14.615 | $13.86 | $14.13 | 3.6M |
| Sep 25, 2026 | $14.62 | $14.89 | $14.23 | $14.25 | 3.22M |
| Sep 24, 2026 | $13.82 | $15.07 | $13.535 | $14.52 | 6.27M |
| Sep 23, 2026 | $15.55 | $15.55 | $13.94 | $13.945 | 4.42M |
| Sep 22, 2026 | $15.17 | $15.775 | $15.085 | $15.55 | 4.77M |
| Sep 21, 2026 | $14.96 | $15.29 | $14.60 | $15.04 | 4.15M |
| Sep 18, 2026 | $15.41 | $15.47 | $14.51 | $14.77 | 8.69M |
| Sep 17, 2026 | $15.83 | $16.32 | $14.92 | $15.34 | 7.55M |
| Sep 16, 2026 | $16.31 | $16.64 | $15.19 | $15.36 | 6.09M |
| Sep 15, 2026 | $16.135 | $16.29 | $15.535 | $16.25 | 4.69M |
| Sep 14, 2026 | $16.06 | $16.53 | $15.97 | $16.16 | 2.37M |
| Sep 11, 2026 | $16.05 | $16.54 | $15.87 | $15.88 | 2.88M |
| Sep 10, 2026 | $15.37 | $17.25 | $15.37 | $16.03 | 8.25M |
| Sep 9, 2026 | $16.06 | $16.70 | $15.67 | $15.70 | 4.04M |
| Sep 8, 2026 | $15.88 | $16.65 | $15.68 | $16.28 | 4.26M |
Latest ERAS news
The latest Smart Investors Daily articles mentioning ERAS.
Stock researchCompany · Forecast
Company
Market Activity
Research & News
Loading stock research…